Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862002460
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
ZIDOVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077267On Market Since
9/19/2005
Pharmacological Classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors
Related Drugs
Same classification
NEVIRAPINE 200 MG TABLET
Generic
65862002760•Aurobindo Pharma Limited
$0.1314
per EA
NEVIRAPINE 200 MG TABLET
Generic
00378405091•Mylan Pharmaceuticals Inc.
$0.1472
per EA
NEVIRAPINE 200 MG TABLET
Generic
31722050560•Camber Pharmaceuticals Inc.
$0.1472
per EA
NEVIRAPINE 200 MG TABLET
Generic
33342000409•Macleods Pharmaceuticals Limited
$0.1472
per EA
NEVIRAPINE 200 MG TABLET
Generic
65162020906•Amneal Pharmaceuticals LLC
$0.1556
per EA
ENTECAVIR 0.5 MG TABLET
Generic
16714071701•NorthStar Rx LLC
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
31722083330•Camber Pharmaceuticals Inc.
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
31722083390•Camber Pharmaceuticals Inc.
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
42494045730•Cameron Pharmaceuticals
$0.2110
per EA
ENTECAVIR 0.5 MG TABLET
Generic
42806065830•Epic Pharma LLC
$0.2110
per EA